Transcatheter aortic valve implantation (TAVI) is assuming a major role in the routine
management of patients with aortic stenosis. Surgical aortic valve replacement is generally …

The first human transcatheter aortic valve implantation (TAVI) in 2002, and several
subsequent single-center series, showed the feasibility of this new approach for the …

In the early 1990s, the idea of Transcatheter Aortic Valve Implantation (TAVI) emerged from
clinicians by the insight that the long-term hemodynamic and clinical results of aortic balloon …

Surgical aortic valve replacement (SAVR) is currently the standard of care to treat patients
with severe symptomatic aortic stenosis (AS) and is generally accepted to alleviate …

The development of transcatheter aortic valve implantation (TAVI) by our group has been a
20-year odyssey. In 1993, postmortem studies validated the concept of intravalvular stenting …

Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and surgical aortic valve replacement can improve symptoms and …

Background: Transcatheter aortic valve implantation (TAVI) is a rapidly evolving strategy for
therapy of aortic stenosis. We describe the effect of the learning curve from the first 270 high …

The efficacy of transcatheter aortic valve implantation (TAVI) in high surgical risk and
inoperable patients with severe aortic stenosis (AS) is rapidly gaining credibility with an ever …

Patients with severe symptomatic aortic stenosis have a poor prognosis with medical
management alone, and balloon aortic valvuloplasty has failed to provide durable clinical …

Since the first groundbreaking procedure in 2002, transcatheter aortic valve implantation
(TAVI) has revolutionized the management of aortic stenosis (AS). Through striking …